- Government told Parliament today, how far trial of indigenous corona vaccine
- Union Minister of State for Home Affairs Nityananda Rajay gave information in Rajya Sabha
- He told that three vaccines are in the advanced stage of trial
The government said on Wednesday that the development of the corona virus vaccine was underway in various stages and more than 30 vaccine companies were supported, of which three are in the advance trial phase while four are in the pre-clinical development stage.
Government told Rajya Sabha, where vaccine trial reached
Minister of State for Home Nityanand Rai gave this information to the Rajya Sabha in a written reply. He said that four pre-clinical trials of vaccine development trials are in the trial stage. He said that 13 clinical trials of some pre-existing drugs are underway to create a portfolio of treatment options aimed at Kovid-19 patients.
Individual stages running test
He said, ‘More than 30 vaccine companies have been supported which are in various stages of development. Three company stages are in advance stage of first, second and third. More than four pre-clinics are in the trial stage. Rai said that on August 7, under the NITI Aayog, a National Expert Group has been constituted for the purpose of using vaccine for Kovid-19.
Health Minister also gave information on the vaccine
Central Health Dr. Harsh Vardhan has claimed that if all goes well, the corona vaccine will be made by the end of this year. He told that by the end of this year, India Biotech vaccine can be given to Covaxin country. The Union Minister also said that in the first quarter of 2021, we will be ready to use the vaccine. He said that work is going on in the country on three vaccines. Harshvardhan said that by the end of this year, the trial of Swadesi vaccine will be completed.
Harshvardhan told who will get the first vaccine?
The Union Minister said that after the vaccine is created, first of all health workers and frontline workers will be found. After this, priority will be given to the elderly and patients with critical illnesses.